Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.42 |
| ▸ | PRCP | P42785 | 2/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | TLR2 | O60603 | 2/20 | 0.34 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 3/20 | 0.33 |
| ▸ | HTR2B | P41595 | 2/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21949019 | 0.94 | TERT (0.39) | TERTPRCPDPP7MEN1KMT2A | |
| SCHEMBL22018478 | 0.94 | TERT (0.41) | TERTPRCPDPP7MEN1KMT2A | |
| SCHEMBL29308671 | 0.93 | TERT (0.41) | TERTPRCPDPP7MEN1KMT2A | |
| SCHEMBL22019122 | 0.92 | TERT (0.40) | TERTPRCPDPP7MEN1KMT2A | |
| SCHEMBL29308198 | 0.92 | TERT (0.40) | TERTPRCPDPP7MEN1KMT2A | |
| SCHEMBL29308356 | 0.88 | TERT (0.40) | TERTPRCPDPP7MEN1KMT2A | |
| SCHEMBL29308374 | 0.86 | TERT (0.39) | TERTPRCPDPP7MEN1KMT2A | |
| SCHEMBL22018582 | 0.85 | PRCP (0.40) | TERTPRCPDPP7MEN1KMT2A | |
| SCHEMBL29630716 | 0.85 | DPP7 (0.38) | TERTPRCPDPP7MEN1KMT2A | |
| SCHEMBL22922937 | 0.85 | KEAP1 (0.40) | TERTKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020099925-A2 | PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES | YUYU PHARMA, INC. (KR) | 2020-05-22 | — | — | WO | disclosed |